UNSPSC 51422432: Hydrocortisone probutate

This classification denotes an anti-inflammatory agent with the molecular formula C28H40O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O6550D6K3A, chemically known as 11.beta.-hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregn-4-ene-3,20-dione, but more generally known as hydrocortisone probutate, which bears US NIH Compound Identifier 636398. European Medicines Agency schedules hydrocortisone probutate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08065MIG.

UNSPSC 51422432 Hydrocortisone probutate is a Commodity code for a specific pharmaceutical product; however, the recent state and local procurement activity tagged under this code does not reflect purchases of hydrocortisone probutate. Seminole County, Florida issued IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems, a public-health emergency-response procurement entirely outside the scope of topical corticosteroid medications. The mismatch between the code's nominal pharmaceutical category and the actual work being solicited suggests either a cataloging error in the underlying state or local procurement system or a misalignment in how the opportunity was tagged at posting.

The available record does not support recent activity in hydrocortisone probutate procurement by state and local entities. The single opportunity present in the data stream—Seminole County's naloxone and deactivation-systems purchase—falls outside the code's defined product scope and provides no usable signal about actual demand for hydrocortisone probutate in state and local markets. Firms evaluating this code should verify current procurement classifications and pursue direct engagement with state pharmaceutical-supply procurement offices or health-department purchasing to identify genuine demand signals.